Creegan & Nassoura Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-9,173
| Closed | -$596K | – | 69 |
|
2019
Q4 | $596K | Buy |
+9,173
| New | +$596K | 0.6% | 54 |
|
2016
Q3 | $960K | Buy |
12,128
+1
| +0% | +$79 | 1.12% | 40 |
|
2016
Q2 | $1.01M | Sell |
12,127
-499
| -4% | -$41.6K | 1.2% | 37 |
|
2016
Q1 | $1.16M | Hold |
12,626
| – | – | 1.37% | 31 |
|
2015
Q4 | $1.28M | Sell |
12,626
-259
| -2% | -$26.2K | 1.45% | 30 |
|
2015
Q3 | $1.27M | Buy |
12,885
+1
| +0% | +$98 | 1.44% | 28 |
|
2015
Q2 | $1.51M | Hold |
12,884
| – | – | 1.57% | 30 |
|
2015
Q1 | $1.26M | Sell |
12,884
-250
| -2% | -$24.5K | 1.3% | 35 |
|
2014
Q4 | $1.24M | Buy |
+13,134
| New | +$1.24M | 1.26% | 35 |
|